Roivant Sciences ROIV
NASDAQ ROIV
$41.19 +0.52 (+1.28%)
At close: Nov 10, 2026 · 4:00 PM EST

Roivant Sciences (ROIV) Long-Term Debt Repayments (2021 - 2024)

Updated

Roivant Sciences (ROIV) recorded Long-Term Debt Repayments of $774,000 in FY2025 (year ended Mar 31, 2025), down 50.0% from $1.55 million in FY2024.

Analysis

Roivant Sciences (ROIV) Long-Term Debt Repayments (2021 - 2024) Analysis & Trends

  • Per Business Quant data, ROIV's Long-Term Debt Repayments was $1.55 million in FY2024 (+123.6%) and $692,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Roivant Sciences 29.81 Bn 13.51 Bn 31.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 49.09 Mn
Sep 30, 2024 1.83 Mn
Jun 30, 2024 1.83 Mn
Mar 31, 2024 7.67 Mn
Dec 31, 2023 7.66 Mn
Sep 30, 2023 7.57 Mn
Jun 30, 2023 7.81 Mn
Mar 31, 2023 8.04 Mn
Dec 31, 2022 7.42 Mn
Sep 30, 2022 7.34 Mn
Jun 30, 2022 7.34 Mn
Jun 30, 2021 21.59 Mn
API Access

Roivant Sciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ROIV&period=max&api_key=YOUR_API_KEY